Teisinės aplinkos elementų įtaka farmacijos verslui

LTStraipsnyje nagrinėjamos įstatymų ir kitų teisės aktų nuostatos, reglamentuojančios farmacijos verslą ir tiesiogiai įtakojančios farmacinės įmonės veiklą. Teisės aktai lyginami su Europos Sąjungos (toliau- ES) direktyvomis ir ES šalių teisine farmacijos srities patirtimi. Pateikiamos rekomendacijos teisės aktų tobulinimui, harmonizuojant juos su ES teise ir suvienodinant Lietuvos bei ES šalių įmonių konkurencines galimybes.

ENArticle analyses the legal acts of the Republic of Lithuania, which regulate pharmaceutical business. These laws are compared with EU Directives and essential differences are outlined, which have the direct influence on the performance and results of pharmaceutical company's work in Lithuania. The article contains the analytical data about the laws and regulations in all fields of pharmaceutical business as well as comparison with EU Directives and EU countries legal practice. The differences in the Law on VAT, Law on Pharmaceutical activity and Law on Public Procurement are found as most important in limiting pharmaceutical activities and decreasing competition ability of pharmaceutical companies in Lithuania. The direct negative impact on company's activities have also the elements of numerous governmental regulations and orders, regulating drug registration, charity, quality control etc., increasing significantly the costs of activity, protecting state institutions, violating the free market economy rules and free competition. The article presents summary of most important elements of legal environment, which have to be changed in the process of harmonisation with EU in order to reach the equal conditions for all the participants of pharmaceutical market.